How to choose a GLP-1 program: what to compare

Safety info: Compounded semaglutide and tirzepatide are not FDA-approved. GLP-1 medicines may cause serious side effects, including possible thyroid tumors. Do not use if you or your family have a history of MTC or MEN 2. Full safety information

To choose a GLP-1 program, start with the clinical care around the medication: a licensed clinician who screens you before prescribing, adjusts your dose as you respond and stays reachable afterward, plus regular metabolic labs and health coaching. Then match the medication and format to your health and routine, confirm that any compounded drug comes from a state-licensed pharmacy, and add up the full monthly cost, including labs, visits and shipping. Compare prices only among the programs that clear those checks.

What a clinically complete GLP-1 program includes

Semaglutide and tirzepatide reduce appetite and act on blood sugar regulation, and our guide to what to know before starting GLP-1 therapy covers how they work and how to prepare. This guide is about the care that surrounds the medication, because that is where programs differ most.

Services that prescribe GLP-1s tend to follow one of two models. In a prescription-only service, you complete a short online intake, receive a prescription or a shipment, and are largely on your own after the first order. In a clinical program, the medication is one part of a coordinated plan that includes candidacy screening, supervised dose titration, metabolic labs, coaching and a care team you can reach between visits. Both may call themselves a program, so compare what each one does after you enroll.

If you are weighing weight loss options more broadly, including programs that do not use medication, our framework for comparing online weight loss programs covers the general checks. The sections below are specific to GLP-1 care.

What to compare	Prescription-only service	Clinical program
Who reviews you	Self-reported form, limited clinician review	Licensed clinician reviews history, medications and contraindications
Dose changes	Fixed dose or self-directed	Stepped up by a clinician based on your response
Follow-up	Help desk or general inbox	Ongoing access to the clinical team
Labs	Usually none, or extra cost	Metabolic labs on a set schedule
Coaching	Rarely included	Regular sessions with a health coach
What the price covers	Medication, with add-ons billed separately	Medication, clinical care, labs and coaching

The prescription-only model has real advantages: a lower upfront price, fast access and little friction. What it leaves out tends to show up later. Without supervised titration, side effects are harder to manage. Without labs, metabolic changes can go unnoticed. Without coaching and follow-up, there is less support for the habits that help results last.

Candidacy and screening before a prescription

A sound program starts before anything is prescribed. A licensed clinician should review your health history, current medications and any conditions that make a GLP-1 unsafe, and should follow up when an answer raises a question. If enrollment is a self-reported form followed by a shipment, keep looking.

For the brand-name GLP-1 medications approved for weight management, the labeled criteria are a body mass index (BMI) of 30 or higher, or 27 or higher with at least one weight-related condition such as type 2 diabetes, high blood pressure, abnormal cholesterol, sleep apnea or fatty liver disease. Guidelines recommend offering medication alongside changes to eating and activity.

Meeting a BMI threshold does not settle the question. A clinical reference on GLP-1 receptor agonists from the NIH lists a personal or family history of medullary thyroid carcinoma as a contraindication and flags pancreatitis risk, and other NIH-hosted clinical guidance also lists multiple endocrine neoplasia syndrome type 2 (MEN2). Certain gastrointestinal conditions and drug interactions can also lead a clinician to recommend against treatment. A brief online form is poorly suited to catching these, which is why clinician review matters.

Screening also records your starting metabolic picture, the baseline that later labs and weight changes are measured against. Ask who reviews your intake, what credentials they hold, and whether the same team manages your care after the first prescription.

Dose titration and follow-up care

Semaglutide and tirzepatide both start at a low dose and increase in steps on an established schedule. Moving up too quickly tends to worsen gastrointestinal side effects, which are among the most common reasons people stop early. Staying at a low dose for too long can limit results. In a clinical program, each step up is a clinician’s decision based on how you are responding, and a program that sets one dose at intake and leaves it there is skipping that work.

The most common side effects, such as nausea, constipation, fatigue and occasional reflux, are usually manageable with active support. A care team can slow your titration, pause a dose increase or suggest ways to ease stomach symptoms. A medication-only service may send you to a help desk that tells you to talk to your doctor, which is hard to act on when the service has no clinician following your care.

Ongoing access is what keeps that support available. When people run into side effects, dosing questions or a plateau with no one to ask, stopping the medication can seem like the only option. A secure messaging channel answered by the clinical team gives you a place to raise concerns early. Ask what hours messages are answered, who reads them, and whether they go to clinicians or a general support inbox. A chatbot or ticket queue is a weaker substitute.

Needs also change over months of treatment. Doses may need adjusting as weight and lab values shift. Rapid weight loss raises the risk of losing muscle, which calls for guidance on protein and resistance training. Plateaus are an expected part of GLP-1 therapy, and a program with regular follow-up can look at your weight trend, labs and symptoms before deciding whether to adjust the dose, the plan or your coaching. A clinical review of long-acting GLP-1 receptor agonists in Diabetes, Metabolic Syndrome and Obesity emphasizes that effective management depends on ongoing guidance across several areas of care, which a single prescribing visit cannot supply.

Medication choices to discuss with your clinician

A program’s medication options set the limits of what your care can look like, so check what each program offers before you enroll. The choice itself should come from you and your clinician together, based on your history, preferences and how you tolerate treatment.

Semaglutide or tirzepatide

Semaglutide and tirzepatide are the GLP-1 medications most programs offer. They differ in how they act on the body, in the formats available and in their titration schedules, and our comparison of semaglutide and tirzepatide covers those differences in detail. When choosing a program, ask whether it offers both, how a clinician decides which to recommend for you, and what happens if the first medication does not suit you.

Weekly injection or daily tablet

Most GLP-1 treatment is a once-weekly injection. Semaglutide is also available as a daily tablet, which some people prefer if they dislike needles, though tablets come with their own routine, such as taking them on an empty stomach. Tirzepatide is given by injection only. Your preference is a fair input, and so is clinical suitability, so a program that offers both formats should have a clinician help you choose. The right format is one your clinician agrees is appropriate and one you can keep up on a busy week.

Brand-name or compounded

Brand-name GLP-1 medications, such as Wegovy and Zepbound, are FDA-approved finished drug products made by Novo Nordisk and Eli Lilly. They follow standardized manufacturing and have been studied in large clinical trials. The trade-off is access and cost. Without coverage they are expensive, and with coverage for weight loss the path often runs through prior authorization, formulary restrictions and prescriber requirements.

Compounded GLP-1 medications are prepared by state-licensed pharmacies for individual patients, under a prescription from a licensed clinician who has decided compounding is appropriate for that patient. They are not FDA-approved, and FDA does not review them for safety, effectiveness or quality. They typically cost less than brand-name drugs without insurance and do not need prior authorization. Compounding is a regulated practice, and a medication from a licensed compounding pharmacy belongs in a different category from a counterfeit or gray-market product. It still involves different trade-offs than an FDA-approved drug, and those are worth discussing with your clinician.

Be wary of marketing that blurs the line between a compounded product and a brand-name drug, for example by borrowing brand names or implying the two are interchangeable. Compounded preparations are not FDA-approved finished products, and a program should say so plainly.

What to check about a compounding pharmacy

Most safety concerns about compounded GLP-1s involve sellers working outside the oversight that makes compounding safe. FDA has raised concerns about unapproved GLP-1 drugs used for weight loss, including dosing errors, improper storage, fraudulent labeling and the use of salt forms of semaglutide that are not approved for compounding. Stanford Medicine reports that poison control centers have seen a more than 15-fold increase in calls related to injected weight loss drugs since 2019, with dosing errors disproportionately associated with compounded products.

Before you enroll, a program should be able to tell you:

• The name of the pharmacy that prepares your medication and confirmation that it is state-licensed. Pharmacies that compound for individual patients, known as 503A pharmacies, are overseen by state boards of pharmacy.
• Documentation of that licensure on request, and where the pharmacy sources its active ingredients.
• Who your prescribing clinician is, since that person carries clinical and legal responsibility for the prescription.
• How to store and dose the medication, in plain written instructions.
• What clinical care surrounds the prescription, including screening, titration oversight, side-effect management and monitoring.

A program that deflects questions about its pharmacy is a reason for caution at any price. FDA has also clarified its policies for compounders as national GLP-1 supply stabilizes, and our guide to compounded tirzepatide and what is legal explains what that means for patients. Brown University Health also has a plain-language overview of compounded weight loss medications and their risks.

Labs and coaching

Metabolic labs

GLP-1 medications affect blood sugar, lipids, kidney function, liver enzymes and nutrient status, and the scale shows only part of that picture. Lab monitoring is how a clinician sees whether treatment is producing the intended effects or changes that call for a response. A useful panel tracks HbA1c and glucose, lipids, and kidney markers such as eGFR and creatinine. If you also take diabetes medication, falling blood sugar can mean those doses need adjusting to avoid hypoglycemia.

Labs only help when someone reviews the results and acts on them. Stable glucose with steady weight loss may support staying at the current dose, while a stall alongside signs of lean mass loss may point to a nutrition change or a titration adjustment. Some low-cost services leave labs out entirely or charge extra for them, which makes them easy to put off. Ask whether labs are included, which panel is drawn, how often and where. Clinical programs often draw metabolic labs quarterly, and our guide to GLP-1 lab work explains what each marker shows.

Health coaching

GLP-1 medications reduce appetite. They do not teach you how to eat enough protein, keep muscle while losing weight, or maintain results after treatment. Appetite changes quickly, and the habits you build around protein, fiber, hydration and strength training shape how you feel and what you keep long term.

A 2024 paper in the American Journal of Lifestyle Medicine reports that health and well-being coaching is documented to improve medication adherence and promote healthy behavior change, and that a coach who understands rapid weight loss can help people persist with treatment. Regular sessions give you a set time to work through meals, side effects and routines. Ask how often you will meet with a coach, whether coaches are certified, and whether coaching is included or billed separately.

Fitting a program to your schedule and preferences

Once the clinical basics are covered, practical details decide whether a program fits your week. A virtual program saves the drive to appointments, but check how visits happen and how quickly routine questions get answered. Many programs answer secure messages during business hours, so if you need a different kind of access, ask before you enroll.

Lab draws are easier when you can walk into a national lab near home or work, so ask which lab networks a program uses. For medication, ask how long it takes to arrive after approval and whether shipping is included in the price.

Then think about how you like to be supported. Some people want frequent coaching sessions and regular check-ins, and others prefer fewer scheduled calls with a messaging channel for questions in between. A weekly injection is one routine a week, while a daily tablet means a daily habit with timing around meals. The best setup is the one you will keep using over months of treatment.

Understanding the full monthly cost

Headline prices vary widely, and the number that matters is the total: medication, clinician visits, labs, coaching, supplies and shipping. Ask for a written list of what the monthly price includes before comparing programs, and check these points:

• Whether the price changes as your dose goes up.
• Whether a discounted first month rises in month two, three or later.
• Whether longer terms are charged upfront, and what the cancellation policy is.
• What labs, follow-up visits or coaching cost if they are not included.
• What you pay if a clinician decides you are not a candidate.

Fragmented pricing can affect your care as well as your budget. When each lab draw or follow-up visit is a separate bill, it becomes easy to skip them, which can leave you on medication without monitoring or lead you to stop before treatment has had time to work.

If you plan to use insurance for a brand-name drug, expect coverage for weight management to vary between plans, often with prior authorization, step therapy and formulary criteria that can delay access by weeks or months. Brand-name costs depend on your coverage and change often, and our guide to tirzepatide cost without insurance walks through the line items to check.

Questions to ask before you enroll

Bring this list to any program you are considering. A credible program answers each question clearly and will put the answers in writing.

• Who reviews my intake, and what are their credentials?
• Will the same clinical team manage my dose changes after the first prescription?
• How do I reach the care team, during what hours, and who answers?
• What happens if I have side effects?
• Which medications and formats do you offer, and how is the choice made?
• Which pharmacy prepares my medication, and is it state-licensed?
• Which labs are included, how often, and where are they drawn?
• How often will I meet with a health coach, and is coaching included?
• What is the total monthly cost, and does it change when my dose changes?
• What do I pay if I am not a candidate, and what is the cancellation policy?

Frequently asked questions

Do I need to have diabetes to qualify for a GLP-1 program?

No. GLP-1 medications began in diabetes care, but brand-name GLP-1 medications are also approved for weight management in adults who meet BMI criteria, with or without diabetes. Whether you are a candidate depends on a clinician’s review of your BMI, weight-related conditions, medications and contraindications.

Can I do a GLP-1 program entirely online?

Many GLP-1 programs are fully virtual. Intake, clinician review, follow-up and coaching happen remotely, labs are drawn at a national lab, and medication ships to your home. The screening should still be a careful review of your history by a licensed clinician.

Who prescribes the medication in an online program?

Online programs often use a care team of physicians, nurse practitioners and physician assistants. The points to confirm are that a licensed clinician reviews your history before prescribing, that physicians lead the clinical team, and that you know how to reach the prescribing team for dose changes and questions after you start.

What happens if I am not a candidate?

A clinician may decline to prescribe if you do not meet eligibility criteria or have a contraindication such as a history of medullary thyroid carcinoma. Before you pay, ask what the program charges if you are not approved, since some charge nothing. A clear no after a careful review is a sign the screening is doing its job.

How long do people usually stay on a GLP-1 program?

Clinicians generally treat GLP-1 therapy as long-term management, with ongoing assessment of how well you tolerate the medication and how it is working. Weight regain after stopping is well documented, so ask what support the program offers once you reach your goal and how it would handle a taper or a pause.

How Elara’s program works

Elara’s physician-guided GLP-1 program is built around the components described in this guide. Clinical care comes from licensed clinicians with OpenLoop Healthcare Partners, PC, a board-certified physician-led team of physicians, nurse practitioners and physician assistants, who review your health history before prescribing. When treatment is appropriate, options include compounded semaglutide by weekly injection or daily tablet, or compounded tirzepatide by weekly injection.

The program includes quarterly metabolic labs at Quest or Labcorp, a certified health coach every 3 weeks (the first call comes around week 3), and secure messaging answered during business hours. Approved medication typically ships within a week, shipping is included, and the price is the same at every dose. There is no charge if you are not approved, and longer terms are prepaid upfront. Availability depends on your state and clinical eligibility.

To see each step in order, read how Elara’s care works, or take the free assessment to find out whether treatment may be right for you.

Compounded medications are prepared by state-licensed pharmacies for individual patients and are not FDA-approved. This article is for general information and is not medical advice. Talk with a licensed clinician about whether GLP-1 treatment is right for you.

Ozempic®, Wegovy® and Rybelsus® are registered trademarks of Novo Nordisk A/S, and Mounjaro® and Zepbound® are registered trademarks of Eli Lilly and Company. Neither company is affiliated with Elara Health and Wellness.